Bladder cancer used to be a disease with very few effective treatment options. That was until two new strategies came on the scene: immunotherapies and antibody drug conjugates. These approaches have changed the way doctors treat bladder cancer, and prolonged the lives of many patients. Dr. Tom Powles, head of Barts Cancer Institute, tells Chuck and Alicia about his work on developing these treatments and where he hopes science will take us next.